Disturbed kidney function is a common occurrence after bone-marrow transplantation. Sepsis, nephrotoxic medications, thrombotic microangiopathy and injury related to haemodynamic alterations are frequently accountable. Recently, attention has been given to immune-mediated glomerular damage, related to graft-versus-host disease. Herein we describe the fatal course of a nephrotic syndrome complicating allogeneic stem cell transplantation in a young woman with long-standing paroxysmal nocturnal haemoglobinuria. A post-mortem kidney biopsy revealed amyloidosis of the AA type. Physicians should be aware of the possibility that infections and inflammation accompanying the post-transplantation period may rarely promote the development of systemic amyloidosis or exacerbate silent pre-existing disease.
Background
Disturbed kidney function in the course of stem cell transplantation is common. Drug nephrotoxicity, acute kidney injury related to infection and haemodynamic instability, thrombotic microangiopathy, kidney hypoperfusion with sepsis or hepatic veno-occlusive disease and immunemediated injuries related to graft versus host disease are among the frequent causes [1] [2] [3] . Herein we describe a female patient who sustained several types of kidney injury in the course of allogeneic stem cell transplantation. Her death, 3 months after transplantation, was due to severe nephrotic syndrome of unanticipated aetiology complicated by sepsis.
Case report
A 20-year-old non-Jewish Russian woman (a medical tourist in Israel) was admitted to our bone-marrow transplantation department. At the age of 10, she received chloramphenicol for bacterial dysentery. Shortly after, aplastic anaemia developed. She was treated with cyclosporine, corticosteroids, blood products, granulocyte stimulating factor (GCSF) and anti-thymocyte globulin (ATG). In the last 4 years, she experienced repeated febrile episodes accompanied by haemolysis. A recent work-up disclosed paroxysmal nocturnal haemoglobinuria (PNH). The patient was a carrier of hepatitis C virus. There was no family history of kidney disease.
On examination, the patient appeared thin, pale and chronically ill, but not debilitated, and not in acute distress. Laboratory findings are displayed in Table 1 . Stick urinalysis was negative for blood and protein. She was treated with a myeloablative sequence consisting of fludarabine, cyclophosphamide and ATG along with prophylactic cyclosporine, acyclovir and cotrimoxazole, followed by infusion of 7.17×10 8 stem cells from a suitable donor (C-locus mismatched, O + to AB + , female-to-female) ('Day 0'). On Day −4, severe haemolysis requiring accelerated transfusions (Table 1) was associated with acute kidney injury, peak serum creatinine 282 µmol/L (Day 14), with subsequent normalization (Day 24). The period following transplantation was remarkable for non-engraftment requiring daily transfusions of blood products. Antibiotics and voriconazole were used to fight blood-stream bacterial infections and presumable pulmonary aspergilloma, respectively. Cytomegalovirus infection was suppressed with foscarnet (begun on Day 44). GVHD, manifesting with skin rash and bloody diarrhoea, responded to parenteral and topical corticosteroid combination.
On Day 45, a top-up transfusion of 13.22×10 8 samedonor stem cells resulted in stable leukocyte counts by Day 56. Several days earlier, the patient developed proteinuria and moderate kidney dysfunction (peak creatinine 155 µmol/L, Day 55) accompanied by severely disturbed mineral metabolism ( Table 1) that were attributed to foscarnet nephrotoxicity. Despite discontinuation of foscarnet, proteinuria progressed rapidly, resulting in profound hypoalbuminaemia. Treatment with diuretics, freshfrozen plasma and low-dose enalapril partially controlled fluid overload. At the same time, progressive cholestatic liver enzyme elevation was compatible with GVHD and/or active hepatitis C (PCR of her serum was positive at >10 8 IU/mL). Following plasmapheresis and intravenous immunoglobulins, serum creatinine improved (Table 1) , but proteinuria persisted. Ultrasonography showed enlarged kidneys, which were of normal size in a previous CT scan. The liver and spleen were also slightly enlarged compared to admission. The patients' functional capacity gradually improved.
A week later (Day 89), the patient presented with leg pain and fever. She was mildly icteric with signs of skin and soft tissue infection. Laboratory examination disclosed pancytopenia. Intravenous wide-spectrum antibiotics were started. The patient developed oliguria and hypotension, was transferred to the intensive-care unit and 12 h later died despite mechanical ventilation and vasopressor support. Three sets of blood cultures subsequently yielded Escherichia coli and Klebsiella pneumonia.
Biopsy findings
A percutaneous kidney biopsy was performed 2 h after death. Histological examination (Figure 1a-d) revealed acute tubular necrosis and massive mesangial deposits of amyloid A. Deposits of amyloid were identified in arterioles as well. Retrospectively, amyloid A deposits were also found in colonic mucosa from a biopsy taken on Day +66 that showed changes compatible with acute on chronic GVHD (Figure 1e-f) . No amyloid was found in bone marrow that was obtained on Days −60 and +15 (not shown).
Discussion
During the course of her illness, our patient's kidneys sustained several injuries. Her principal underlying disease, PNH, was unquestionably linked to repeated episodes of severe intravascular haemolysis and reversible tubular injury. Following myeloablation, our patient remained agranulocytotic for a period of 8 weeks, during which repeated episodes of infection required multiple antimicrobial regimens. Notorious among the latter was foscarnet [4] [5] [6] , which our patient received to control cytomegalovirus infection prior to establishment of protective white cell counts.
The aforementioned alterations noted in our patient's kidney function were shaded by severe nephrotic syndrome. Profound hypoalbuminaemia and malnutrition have undoubtedly underlined the fulminant gram-negative sepsis to which our patient succumbed. Possible diagnoses considered pre-mortem included minimal change disease, membranous glomerulopathy, HCV-related mesangiocapillary glomerulonephritis, thrombotic microangiopathy and crystal-induced glomerular damage (foscarnet). Glomerular lesions have recently been recognized as possible renal involvement in GVHD, often during tapering-off of immunosuppressive agents [1] . However, massive proteinuria was recorded in our patient prior to establishment of functioning bone marrow, and without other evidence of GVHD.
The histological findings in the post-mortem kidney biopsy prompted evaluation for possible amyloidosis. Indeed amyloidosis was found, and was characterized as the AA type. Of note, a colonoscopic biopsy material obtained 23 days prior to our patient's death also revealed deposits of amyloid A in capillary walls. Two essential questions are when and why did our patient develop secondary amyloidosis. Amyloidosis A may complicate chronic diseases with longstanding inflammation, chronic infections or periodic fever syndromes. In up to 7%, the underlying cause remains obscure [7] . Our patient had no signs of systemic amyloidosis at the time of stem cell transplantation. Evidence for de novo amyloidosis is based on normal serum creatinine and negative dipstick for protein on admission, negative retrospective staining of two bone-marrow biopsy specimens and perhaps also normal-sized liver and spleen. Nonetheless, our patient had a 10-year history of PNH, exposing her to repeated infections. A relapsing infection may accelerate amyloidogenesis as much as a chronic inflammatory disorder. In addition, PNH attacks are accompanied by fever, and have an inflammatory component, that may cause acute phase reaction, conceivably including serum amyloid A protein elevation. Our patient may have had subclinical amyloidosis prior to bone marrow transplantation. This condition became clinically relevant upon exposure to the transplantation-related infections.
In summary, like other patients undergoing stem cell transplantation, our patient sustained multiple insults to her kidneys. However, she succumbed to overwhelming sepsis due to nephrotic syndrome with immense proteinuria, which was found-post-mortem-to reflect systemic AA amyloidosis. Although we are not aware of a similar previously reported association, physicians caring for patients after stem cell transplantation should be aware that amyloidosis could be a complication of the procedure.
